Journal
WORLD JOURNAL OF HEPATOLOGY
Volume 14, Issue 1, Pages -Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.4254/wjh.v14.i1.62
Keywords
Hepatitis C virus; Sustained virological response; Direct antiviral agents; Human immunodeficiency virus; Cirrhosis decompensation; Hepatocarcinoma; Extrahepatic complications
Categories
Funding
- Consejeria de Salud, Junta de Andalucia, Integrated Territorial Initiative for the province of Cadiz
- Fondo Europeo de Desarrollo Regional (FEDER) [PI-0076-2017]
- Consejeria de Salud, Junta de Andalucia [PI 0128/2018]
- Instituto de Salud Carlos III, Ministerio de Sanidad, Accion Estrategica en Salud [PI19/01361]
Ask authors/readers for more resources
Loss of follow-up or reinfections hinder the goal of hepatitis C eradication, and chronic HCV infection can cause various liver and extrahepatic alterations. The situation of coinfected individuals is also unique.
Loss of follow-up or reinfections hinder the expectations of hepatitis C eradication despite the existence of highly effective treatments. Moreover, the elimination of the infection does not imply the reversion of those chronic alterations derived from the previous infection by hepatitis C virus (HCV). This review analyzes the risk factors associated with loss to follow-up in diagnosis or treatment, and the possibility of reinfection. Likewise, it assesses the residual alterations induced by chronic HCV infection considering the liver alterations (inflammation, fibrosis, risk of decompensation, hepatocellular carcinoma, liver transplantation) and, on the other hand, the comorbidities and extrahepatic manifestations (cryoglobulinemia, non-Hodgkin lymphoma, peripheral insulin resistance, and lipid, bone and cognitive alterations). Peculiarities present in subjects coinfected with human immunodeficiency virus are analyzed in each section.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available